budesonide/formoterol fumarate/umeclidinium bromide (CP-006)
/ Chenbang Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 09, 2026
CP006-ASTHMA: Efficacy and Safety of CP006 Inhalation Powder in Participants With Asthma
(clinicaltrials.gov)
- P2 | N=150 | Completed | Sponsor: Shanghai Xin Huanghe Pharmaceutical Co., Ltd.
New P2 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1